These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15925541)

  • 21. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
    Fischer K; Scotet E; Niemeyer M; Koebernick H; Zerrahn J; Maillet S; Hurwitz R; Kursar M; Bonneville M; Kaufmann SH; Schaible UE
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10685-90. PubMed ID: 15243159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.
    Hansen DS; Siomos MA; De Koning-Ward T; Buckingham L; Crabb BS; Schofield L
    Eur J Immunol; 2003 Sep; 33(9):2588-98. PubMed ID: 12938235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKT cells: T lymphocytes with innate effector functions.
    Van Kaer L
    Curr Opin Immunol; 2007 Jun; 19(3):354-64. PubMed ID: 17428648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.
    Dhodapkar MV; Geller MD; Chang DH; Shimizu K; Fujii S; Dhodapkar KM; Krasovsky J
    J Exp Med; 2003 Jun; 197(12):1667-76. PubMed ID: 12796469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition.
    Sidobre S; Hammond KJ; Bénazet-Sidobre L; Maltsev SD; Richardson SK; Ndonye RM; Howell AR; Sakai T; Besra GS; Porcelli SA; Kronenberg M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12254-9. PubMed ID: 15304644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product.
    Pasquier B; Yin L; Fondanèche MC; Relouzat F; Bloch-Queyrat C; Lambert N; Fischer A; de Saint-Basile G; Latour S
    J Exp Med; 2005 Mar; 201(5):695-701. PubMed ID: 15738056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling for NKT cell development: the SAP-FynT connection.
    Borowski C; Bendelac A
    J Exp Med; 2005 Mar; 201(6):833-6. PubMed ID: 15781574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury.
    Ström A; Wigren M; Hultgårdh-Nilsson A; Saxena A; Gomez MF; Cardell S; Fredrikson GN; Nilsson J
    Circ Res; 2007 Oct; 101(8):e83-9. PubMed ID: 17885216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
    Gumperz JE
    J Leukoc Biol; 2004 Aug; 76(2):307-13. PubMed ID: 15123775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression in NKT cells: defining a functionally distinct CD1d-restricted T cell subset.
    Wilson SB; Byrne MC
    Curr Opin Immunol; 2001 Oct; 13(5):555-61. PubMed ID: 11544003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
    Miyake S; Yamamura T
    Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD1d and invariant NKT cells at the human maternal-fetal interface.
    Boyson JE; Rybalov B; Koopman LA; Exley M; Balk SP; Racke FK; Schatz F; Masch R; Wilson SB; Strominger JL
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13741-6. PubMed ID: 12368486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
    Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
    Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
    Kinjo Y; Tupin E; Wu D; Fujio M; Garcia-Navarro R; Benhnia MR; Zajonc DM; Ben-Menachem G; Ainge GD; Painter GF; Khurana A; Hoebe K; Behar SM; Beutler B; Wilson IA; Tsuji M; Sellati TJ; Wong CH; Kronenberg M
    Nat Immunol; 2006 Sep; 7(9):978-86. PubMed ID: 16921381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn.
    Bloch-Queyrat C; Fondanèche MC; Chen R; Yin L; Relouzat F; Veillette A; Fischer A; Latour S
    J Exp Med; 2005 Jul; 202(1):181-92. PubMed ID: 15998796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.
    Mattner J; Debord KL; Ismail N; Goff RD; Cantu C; Zhou D; Saint-Mezard P; Wang V; Gao Y; Yin N; Hoebe K; Schneewind O; Walker D; Beutler B; Teyton L; Savage PB; Bendelac A
    Nature; 2005 Mar; 434(7032):525-9. PubMed ID: 15791258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.